Every material Form 8-K Healthpeak Properties filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Healthpeak reported a third-quarter 2025 net loss applicable to common shares of $117.3 million, or $0.17 per share, compared with net income of $85.7 million, or $0.12 per share, a year earlier. The loss reflects $175.8 million of impairment charges on unconsolidated joint ventures. The company cut its full-year 2025 diluted earnings per share guidance to $0.00 to $0.06 from $0.25 to $0.31, while reaffirming its Nareit FFO guidance of $1.78 to $1.84 per share.
Third-quarter Nareit FFO rose to $0.45 per share from $0.44 a year earlier; FFO as Adjusted was $0.46 versus $0.45.
Third-quarter net loss of $117.3 million ($0.17 per share) included $175.8 million of impairments on unconsolidated joint ventures.
2025 diluted EPS guidance lowered to $0.00 to $0.06 from $0.25 to $0.31; Nareit FFO guidance of $1.78 to $1.84 reaffirmed.
Board declared monthly dividends of $0.10167 per share for October, November and December 2025, totaling $0.305 for the fourth quarter.
Healthpeak reported second-quarter 2025 diluted net income of $0.05 per share, down from $0.21 a year earlier, while Nareit FFO was $0.43 per share versus $0.44 and FFO as Adjusted and AFFO rose to $0.46 and $0.44 per share. The company cut its full-year 2025 diluted earnings per share guidance to $0.25 to $0.31 from $0.30 to $0.36 and Nareit FFO guidance to $1.78 to $1.84 from $1.81 to $1.87, while reaffirming its FFO as Adjusted guidance of $1.81 to $1.87 per share.
Q2 2025 diluted net income was $0.05 per share versus $0.21 in Q2 2024.
Q2 2025 Nareit FFO was $0.43 per share versus $0.44; FFO as Adjusted was $0.46 versus $0.45; AFFO was $0.44 versus $0.40.
2025 diluted EPS guidance lowered to $0.25 to $0.31 from $0.30 to $0.36; Nareit FFO guidance lowered to $1.78 to $1.84 from $1.81 to $1.87.
Monthly dividend of $0.10167 per share declared for July, August and September 2025, totaling $0.305 for the third quarter; approximately $2.3 billion of liquidity as of July 24, 2025.
Healthpeak reported first quarter 2025 results, with net income applicable to common shares of $42.4 million, or $0.06 per diluted share, up from $6.5 million, or $0.01, a year earlier. Diluted Nareit FFO rose to $0.45 per share from $0.27, and the company reaffirmed its full-year 2025 guidance, including diluted earnings per share of $0.30 to $0.36.
Q1 2025 diluted net income of $0.06 per share versus $0.01 in Q1 2024; diluted Nareit FFO of $0.45 versus $0.27
Diluted FFO as Adjusted of $0.46 per share versus $0.45; diluted AFFO of $0.43 versus $0.42
2025 guidance reaffirmed: diluted EPS of $0.30 to $0.36 and diluted Nareit FFO of $1.81 to $1.87 per share; monthly dividend of $0.10167 per share for April, May and June
Healthpeak Properties appointed Kelvin O. Moses as Chief Financial Officer and principal financial officer, effective April 24, 2025, under the company's succession plan. Mr. Moses previously served as Executive Vice President – Investments and Portfolio Management and joined the company in 2018. The filing discloses his $550,000 base salary and equity awards, a CFO change that shareholders will want to track.
Kelvin O. Moses appointed CFO and principal financial officer, effective April 24, 2025
Base salary of $550,000, plus eligibility for short-term and long-term incentive plans
Retentive equity award with grant date fair value of $380,000 and performance-based award of $570,000
Accounting, treasury and investor relations leaders remain in place, per the press release
Healthpeak Properties said Chief Financial Officer Peter Scott resigned, effective on notice given April 2, 2025, to become Chief Executive Officer of Healthcare Realty Trust Incorporated (NYSE: HR). The company said the resignation was not due to any disagreement with the company or its external auditor, and Scott is not entitled to severance. The company has a succession plan and expects to name an internal successor in the coming weeks.
Scott informed the company of his resignation on April 2, 2025; the filing and press release are dated April 7, 2025.
Scott is leaving to become CEO of Healthcare Realty Trust Incorporated (NYSE: HR).
Scott is not entitled to any severance payment under the Executive Severance Plan or otherwise.
The company expects to name an internal successor for CFO in the coming weeks.
Healthpeak Properties announced that Chief Operating Officer Thomas Klaritch will retire, stepping down as COO and leader of the outpatient medical segment on March 1, 2025, and leaving employment on September 30, 2025. He will then provide consulting services through the end of 2025 for a fee of $50,000 per month, and his retirement benefits are conditioned on signing a Retirement and Release Agreement. The change affects senior management leadership and the outpatient medical segment, but the filing gives no financial results or guidance.
Klaritch steps down as COO and outpatient medical segment leader effective March 1, 2025
Employment terminates September 30, 2025; consulting services from October 1 to December 31, 2025 at $50,000 per month
Benefits include prorated 2025 bonus based on the average of prior three years' bonuses and prorated 2025 equity awards through September 30, 2025
Benefits are conditioned on signing a Retirement and Release Agreement filed as Exhibit 10.1
Healthpeak reported fourth-quarter 2024 net income of $0.01 per share, down from $0.13 a year earlier, and Nareit FFO of $0.44 per share, down from $0.48, while FFO as Adjusted of $0.46 and AFFO of $0.40 per share were up or flat from the prior year. The company also gave 2025 guidance, including diluted earnings per share of $0.30 to $0.36, and raised its quarterly dividend 1.7% to $0.305 per share, with a planned switch to monthly payments starting April 2025.
Q4 2024 net income of $0.01 per share vs $0.13 in Q4 2023; Q4 total revenues of $697,988 thousand vs $553,652 thousand
Q4 2024 Nareit FFO of $0.44 per share vs $0.48; AFFO of $0.40 vs $0.36
2025 guidance: diluted EPS $0.30 to $0.36 and Nareit FFO $1.81 to $1.87 per share, vs 2024 full-year Nareit FFO of $1.61
Dividend raised to $0.305 per share; monthly dividend expected from April 2025; COO Tom Klaritch and GC Jeff Miller depart December 31, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Healthpeak Properties filing is on SEC EDGAR ↗. 8-K briefs of other companies →